ℹ️
🇬🇧
Search
Search for people relevant for "myeloid"
myeloid
Person
Class
Person
Publication
Programmes
Export current view
MUDr. Petr Smíšek
External person at Second Faculty of Medicine
59 publications
Publications
publication
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study
2022 |
Publication without faculty affiliation
publication
The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01
2014 |
Publication without faculty affiliation
publication
Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group
2013 |
Publication without faculty affiliation
publication
Immunosuppressive therapy combining anti-thymocyte globulin and cyclosporine A in childhood acquired aplastic anaemia - long term-outcomes and risks
2012 |
Second Faculty of Medicine
publication
The relapsed AML 2001/01, 02 study for children with relapsed acute myeloid leukaemia or initially resistant disease has improved outcome
2011 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome
2010 |
Second Faculty of Medicine
publication
Interfant 99 - treatment reflecting unique biology of the infant acute lymphoblastic leukemia. The results in the Czech Republic
2009 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
Second national study AML-BFM 98 improved remission rate and overall survival in children with acute myeloid leukemia in the Czech Republic
2008 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Physical Education and Sport
publication
Unification of treatment of childhood acute myeloid leukemia in the Czech Republic according to AML-BFM 93 study protocol
2004 |
Second Faculty of Medicine
publication
Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study
2024 |
Second Faculty of Medicine
Load more publications (49)
Loading network view...